PracticeAHN Cancer Institute-Med Onc & Infusions at H+W Pavilion Bethel Park
GenderFemale
EducationGannon University
CertificationNational Commission on Certification of Physician Assistants--
About
Stephanie Smrekar
Stephanie Smrekar practices as an Oncologist in Bethel Park, PA.She graduated from Gannon University.
Services
lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease